chr22-27799614-ATGC-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_002430.3(MN1):c.927_929del(p.Gln309del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000467 in 1,519,040 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign,other (no stars).
Frequency
Genomes: 𝑓 0.000060 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00051 ( 0 hom. )
Consequence
MN1
NM_002430.3 inframe_deletion
NM_002430.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.72
Genes affected
MN1 (HGNC:7180): (MN1 proto-oncogene, transcriptional regulator) Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant 22-27799614-ATGC-A is Benign according to our data. Variant chr22-27799614-ATGC-A is described in ClinVar as [Benign, other]. Clinvar id is 438776.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 9 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MN1 | NM_002430.3 | c.927_929del | p.Gln309del | inframe_deletion | 1/2 | ENST00000302326.5 | NP_002421.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MN1 | ENST00000302326.5 | c.927_929del | p.Gln309del | inframe_deletion | 1/2 | 1 | NM_002430.3 | ENSP00000304956 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000600 AC: 9AN: 149982Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
9
AN:
149982
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000512 AC: 701AN: 1369058Hom.: 0 AF XY: 0.000604 AC XY: 407AN XY: 673342
GnomAD4 exome
AF:
AC:
701
AN:
1369058
Hom.:
AF XY:
AC XY:
407
AN XY:
673342
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000600 AC: 9AN: 149982Hom.: 0 Cov.: 33 AF XY: 0.0000956 AC XY: 7AN XY: 73210
GnomAD4 genome
AF:
AC:
9
AN:
149982
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
73210
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign; other
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MN1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 02, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hepatoblastoma Other:1
other, no assertion criteria provided | clinical testing | Donald Williams Parsons Laboratory, Baylor College of Medicine | May 01, 2016 | - 3: Mutations in other consensus cancer genes, not currently considered targetable |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at